BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4381869)

  • 1. The effects of barbiturates on the activity of the catecholamine neurones in the rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Aug; 18(8):556-8. PubMed ID: 4381869
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of ethanol on the activity of central catecholamine neurones in rat brain.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1966 Dec; 18(12):821-3. PubMed ID: 4381667
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of neuroleptics on the activity of central catecholamine neurones.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1967 Apr; 6(7):767-74. PubMed ID: 6031261
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alpha-methyltyrosine and disulfiram on inhibitory function of the caudate nucleus and the catecholamine concentration in the cat brain.
    Arushanyan EB; Stolyarov GV; Tolpyshev BA
    Bull Exp Biol Med; 1974 Aug; 77(2):139-42. PubMed ID: 4433917
    [No Abstract]   [Full Text] [Related]  

  • 6. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of reserpine, alpha-methyl-m-tyrosine, prenylamine, and guanethidine on metrazol-convulsions and the brain monoamine level in mice.
    Pfeifer AK; Galambos E
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):201-11. PubMed ID: 6030237
    [No Abstract]   [Full Text] [Related]  

  • 8. Difference in oral effectiveness of two tyrosine hydroxylase inhibitors.
    Johnson GA; Kim EG; Veldkamp W; Russell R
    Biochem Pharmacol; 1967 Feb; 16(2):401-3. PubMed ID: 6029921
    [No Abstract]   [Full Text] [Related]  

  • 9. On the use of the fluorescence histochemical method to estimate catecholamine content in brain.
    Bacopoulos NG; Bhatnagar RK; Schnute WJ; Van Orden LS
    Neuropharmacology; 1975 Apr; 14(4):291-9. PubMed ID: 1128763
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of -methyl-meta-tyrosine on spontaneous and caudate-induced electroencephalogram activity and regional catecholamines in the cat brain.
    Shellenberger MK
    J Pharmacol Exp Ther; 1971 Jun; 177(3):481-90. PubMed ID: 5568803
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 12. The development of monoamine-containing neurones in the brain of the albino rat.
    Loizou LA
    J Anat; 1969 May; 104(Pt 3):588. PubMed ID: 5804578
    [No Abstract]   [Full Text] [Related]  

  • 13. Regional role of catecholamines in alpha methyl-m-tyrosine- induced electroencephalographic arousal.
    Shellenberger MK; Gordon JH
    Exp Neurol; 1975 Nov; 49(2):370-85. PubMed ID: 1193194
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of a possible interference of alpha-methyl-para-tyrosine pretreatment on the radioenzymatic assay of catecholamines in the rat brain.
    Tizabi Y; Massari VJ; Jacobovitz DM
    J Neurochem; 1979 Oct; 33(4):959-61. PubMed ID: 385810
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of inhibition of catecholamine synthesis on central catecholamine-containing neurones in the developing albino rat.
    Loizou LA
    Br J Pharmacol; 1971 Jan; 41(1):41-8. PubMed ID: 5547761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morphine intoxication on brain catecholamine neurons.
    Gunne LM; Jonsson J; Fuxe K
    Eur J Pharmacol; 1969 Mar; 5(4):338-42. PubMed ID: 4306742
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of alpha-methyltyrosine on operant behavior and brain catecholamine levels.
    Schoenfeld RI; Seiden LS
    J Pharmacol Exp Ther; 1969 Jun; 167(2):319-27. PubMed ID: 5787869
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
    Dominic JA; Moore KE
    Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.